Compositions and methods for targeted cytokine delivery
US-2024376169-A1 · Nov 14, 2024 · US
Immune function development promoter and growth promoter
US10590180B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10590180-B2 |
| Application number | US-201615736961-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2016 |
| Priority date | Jun 19, 2015 |
| Publication date | Mar 17, 2020 |
| Grant date | Mar 17, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention discloses immune function development promoters and growth promoters comprising CCL25. The development of immune functions in a subject can be promoted by ingesting an immune function development promoter according to the present invention. Moreover, growth of a subject can be promoted by ingesting a growth promoter according to the present invention.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for promoting immune function development in a subject, comprising administering Chemokine (C-C motif) ligand 25 (CCL25) protein in a composition to a subject in need thereof, wherein the CCL25 protein is orally administered; with the proviso that the composition is not milk itself obtained from the mother's body. 2. The method according to claim 1 , wherein the subject is an infant. 3. A method for promoting growth of a subject, comprising administering Chemokine (C-C motif) ligand 25 (CCL25) in a composition to a subject in need thereof; with the proviso that the composition is not milk itself obtained from the mother's body. 4. The method according to 3 , wherein the subject is an infant. 5. The method according to 4 , wherein the CCL25 is orally administered. 6. The method according to 3 , wherein the CCL25 is orally administered.
Assignees
Inventors
Classifications
- C07K14/52Primary
Cytokines; Lymphokines; Interferons · CPC title
Dairy proteins · CPC title
Immunostimulants · CPC title
- A61K38/195Primary
Chemokines, e.g. RANTES · CPC title
Other dairy products · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10590180B2 cover?
- The present invention discloses immune function development promoters and growth promoters comprising CCL25. The development of immune functions in a subject can be promoted by ingesting an immune function development promoter according to the present invention. Moreover, growth of a subject can be promoted by ingesting a growth promoter according to the present invention.
- Who is the assignee on this patent?
- Univ Shizuoka Nat Univ Corp
- What technology area does this patent fall under?
- Primary CPC classification C07K14/52. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).